Innovation Pharmaceuticals Inc (IPIX)

[farrell90]

The trial is not adaptive as I thought it might be. The only variation allowed is the possible extension of dosing to 5 days as previously PRed.

Ordinal scale for staging at onset and quantifying results as previously reported.

I read it twice and could not find the dosing.

Nothing surprising on the exclusions.

The primary and secondary outcomes were well explained and reasonable. I thought they were more challenging than other therapeutic trials.

Bottom line if it works it works. We should know soon.

With the slow roll out I hope theywill do an interim report as mentioned previously.

GLTA Farrell